Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3237 Target Snapshot

Cytochrome P450 11B2, mitochondrial · SINGLE PROTEIN · Rattus norvegicus

39Compounds
19Assays
2Approved Drugs
29.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P30099. Use UniProt P30099 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P30099 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 11B2, mitochondrial as ChEMBL target CHEMBL3237, mapped to UniProt P30099. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 11B2, mitochondrial
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL3237
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P30099
Cytochrome P450 11B2, mitochondrial
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 11B2, mitochondrial is the right protein anchor across sources, using UniProt P30099 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 11B2, mitochondrial
UniProt AccessionP30099
Component TypeProtein
Sequence Length510 aa

Cytochrome P450 11B2, mitochondrial

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 11B2, mitochondrial, mapped to UniProt P30099. Sequence length is 510 aa.

Mapped IDP30099
Review nameCytochrome P450 11B2, mitochondrial
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Approved
3
Phase II
Assay Mix

Activity Type Distribution

IC5029.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3099704 9.0 IC50 1.0 Preclinical
CHEMBL4080420 8.89 IC50 1.3 Preclinical
CHEMBL4067000 8.66 IC50 2.2 Preclinical
CHEMBL4098297 7.85 IC50 14.0 Preclinical
CHEMBL3099696 7.62 IC50 24.0 Preclinical
CHEMBL4080256 7.48 IC50 33.0 Preclinical
CHEMBL4071689 7.11 IC50 77.0 Preclinical
CHEMBL3099695 6.96 IC50 111.0 Approved
CHEMBL287677 6.93 IC50 118.0 Clinical
CHEMBL4099824 6.52 IC50 300.0 Preclinical
Distribution

pChEMBL Value Distribution

5
5.0
2
5.5
1
6.0
3
6.5
2
7.0
2
7.5
0
8.0
2
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

OSILODROSTAT
CHEMBL3099695
Approved 2020
Assay Landscape

Assay Landscape

19
Total Assays
16
Tested Compounds
2
Assay Types
Binding — 11 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 5 9 7.8
single protein format 4 7 5.2
assay format 2 0
Functional — 8 assays, 8 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 6 5.0
tissue-based format 4 2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine